Ginkgo Bioworks Holdings First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Yahoo Finance · 20 hours ago
Open | 0.7970 |
High | 0.8276 |
Low | 0.7202 |
Mkt Cap | 1.68B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 0.9200 |
52 Wk. Low | 0.7200 |
52 Wk. High | 2.5450 |
Related stocks
American biotechnology company
Ginkgo Bioworks is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 37.94M | 53.00% ▼ |
Net Income | -165.91M | - |
Diluted EPS | -0.08 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.08 | - |
Q1 2024 | -$0.08 | -$0.08 |
Q4 2023 | -$0.10 | -$0.11 |
S&P 500^GSPC | 5,222.68+8.60 (+0.16%) |
Dow 30^DJI | 39,512.84+125.08 (+0.32%) |
Nasdaq^IXIC | 16,340.87-5.40 (-0.03%) |
5.39+0.19% | |
Bitcoin USDBTC-USD | 61,014.05+0.30% |
36.23-0.60% |